Golbourn B, Ho B, Bondoc A, Luck A, et al. A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors. Neuro Oncol 2024;26:1895-1911.
PMID: 38981018